Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Begmiron-S 50 Tablet ER

Prescription Icon
Prescription Required

Marketer

Fawn Incorporation

Salt Composition

Mirabegron (50mg) + Solifenacin (5mg)

Overview Begmiron-S 50 Tablet ER

Combiflex-50 Extended Release tablets combine two active ingredients to manage overactive bladder symptoms. This medication offers relief from frequent urination, urgency, and incontinence. Always adhere to your physician's prescribed dosage and schedule for Combiflex-50 ER; it can be taken with or without food, ideally at the same time daily. Discontinuing treatment prematurely may exacerbate symptoms, so complete the full course as directed. Commonly reported side effects include elevated blood pressure, upper respiratory tract inflammation, urinary infections, and headaches. Report any persistent or bothersome side effects to your doctor immediately. Prior to starting treatment, disclose all other medications and any existing health conditions, including pregnancy or breastfeeding. Individuals with liver or kidney impairment should exercise caution, requiring regular monitoring by their healthcare provider.

Primary Ingredients of Begmiron-S 50 Tablet ER

No text provided to rephrase.

Uses of Begmiron-S 50 Tablet ER

Symptoms indicative of an overactive bladder

Major Benefits of Begmiron-S 50 Tablet ER:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Begmiron-S 50 Tablet ER can be administered with or without food, although consistent timing is recommended.

Common Side effects of Begmiron-S 50 Tablet ER:

  • High blood pressure
  • Nasopharyngitis (inflammation of the throat and nasal passages)
  • Urinary tract infection
  • Headache
  • Dryness in mouth
  • Constipation
  • Increased heart rate
  • Blurred vision

How to use Begmiron-S 50 Tablet ER:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the tablet whole; avoid crushing, chewing, or breaking it. Begmiron-S 50 Tablet ER can be administered with or without food, though consistent timing is recommended.

How Begmiron-S 50 Tablet ER works:

Begmiron-S 50 Extended-Release tablets contain Mirabegron and Solifenacin, two medications that synergistically manage urinary symptoms. Mirabegron, a beta-3 adrenergic agonist, promotes bladder muscle relaxation by stimulating specific bladder receptors. Solifenacin, an antimuscarinic agent, achieves a similar effect through a different mechanism, also relaxing bladder musculature. This dual action reduces urinary urgency, frequency, and incontinence.

SAFETY ADVICE

AlcoholAlcoholCAUTION

Exercise caution when combining Begmiron-S 50 Tablet ER and alcohol. Seek medical advice before doing so.

PregnancyPregnancyCONSULT YOUR DOCTOR

Data on Begmiron-S 50 Tablet ER use in pregnancy is lacking. Seek medical advice from your physician.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Data on the compatibility of Begmiron-S 50 Tablet ER with breastfeeding is currently lacking. Seek medical advice from your physician.

DrivingDrivingCONSULT YOUR DOCTOR

The effect of Begmiron-S 50 Tablet ER on driving ability is undetermined. Refrain from driving if you exhibit symptoms impairing concentration or reaction time.

KidneyKidneyCONSULT YOUR DOCTOR

Insufficient data exists regarding Begmiron-S 50 Tablet ER's application in individuals with renal impairment. Physician consultation is recommended.

LiverLiverCONSULT YOUR DOCTOR

Insufficient data exists regarding Begmiron-S 50 Tablet ER use in individuals with hepatic impairment. Physician consultation is advised.

What if you forget to take Begmiron-S 50 Tablet ER :

NA

Facts to Know About Begmiron-S 50 Tablet ER

LabelValue
Developing Habits No.
Treatment Category Urology
Begmiron-S 50 Tablet ER
451
MRP 550
18% off